Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. The capsules can be used with an array of pharmaceutically approved lipid-based excipients, offering formulation flexibility from LFCS type I to type IV and effective API containment.
This presentation will discuss:
- Illustration of how to formulate, characterize lipid formulations starting from API physico-chemical and biological attributes
- Details of scaling up safely for highly potent API
- Demonstration of efficiency for early stage clinical trials